Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 423 (OTC: $CSUI)
(CSE: $IPOT.C) (OTC: $OWPC)(TSX: $VLNS.TO) (CSE: $HOLL.C)
Delta,
Kelowna, BC, June 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a
global news source covering leading sectors including marijuana and hemp stocks
and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/06041CSUI-IPOT-OWPC-VLNS-HOLL.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Isracann
Biosciences Inc. (CSE:
IPOT) (OTC:
ISCNF) announced their
support of the recent government approval permitting the export of cannabis for
sale to foreign medicinal markets.
On
May 13, 2020, the Israeli Ministry of Economy signed a Free Export Order for
medical cannabis products. The order allows the government to implement a
medical cannabis decision that was previously signed in 2019. The order was
announced to go into effect 30 days from the signing, at which time licensed
producers of medical cannabis in Israel will be able to apply for an export
permit to ship product to international markets. Accordingly, Isracann has
tasked its regional consultants with ensuring applications for an export permit
will be made as soon as possible.
As
reported by Israel’s Globes Business News, the Ministry of Health stated it
will permit exports while ensuring adequate supplies for medical cannabis in
the Israeli market. During the second half of 2019, after the Health Ministry's
new medical cannabis reform came into effect, the tightened medical cannabis
manufacturing and processing standards proved complex for many producers, while
at the same time making it easier for patients to obtain licensed access
creating a gap in supply. The media outlet further reported that the Ministry
of Economy has announced that revenue from medical cannabis exports is expected
to reach hundreds of millions of dollars each year. In the sector, it is
estimated that if the country leverages early approval for exports, a more
significant place could be taken in the global market.
Isracann
CEO Darryl Jones notes, “As we have noted previously, supply in both the
domestic and European markets is lagging behind demand, especially in Europe as
more countries work on less restrictive regulations. Our timely ability to jump
into the gap will be a great opportunity for Isracann. Additionally, our
marketing strategy aims to leverage Israeli-branded products as fundamentally
superior due to the unique environment and advanced agronomics Israel offers.
We look forward to working with our consultants and the Ministry to ensure we
are ready to apply for export permitting as soon as the application process is
clarified.”
The
Company also announced today that Mr. Matt Chatterton has been promoted from
his role as VP, Operations to the position of Chief Operating Officer. His
proven background in manufacturing including project and facility management,
logistics, supply side processes and procedures has been utilized extensively
since joining the Company. Mr. Chatterton has fully engaged with every aspect of
the operation within Israel. His intimate knowledge and relationships across
the organizational structure and understanding of the Company’s goals will
continue to prove invaluable as commercialization advances.
“I
am very grateful for this vote of confidence and the latitude it provides,” Mr.
Chatterton comments. “As we move ahead into commercialization, I am confident
that our team can quickly advance towards revenue generation and sustainable
growth.”
The
Company wishes to acknowledge and thank Mr. Israel Moseson who steps down from
his role as COO. As a founding member of Isracann, he was instrumental in the
early stage growth of the business. We sincerely wish him well in his future
endeavors.
One World Pharma
Inc.
(OTC:
OWPC) announced that
effective immediately, NBA legend, international entrepreneur and
philanthropist Isiah Thomas has been appointed as its CEO and Vice-Chairman of
the Board of Directors. Mr. Thomas will replace founder and CEO Craig Ellins
who is retiring.
Isiah
Thomas, while forever known for his Hall of Fame career as a 12-time NBA All
Star, two-time NBA champion, and inclusion as one of the 50 Greatest Players in
NBA History, is an accomplished and highly regarded international business
executive and investor with a portfolio of companies he has developed via Isiah
International Inc. Mr. Thomas has previously served on the Chicago Stock
Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors,
Popcorn Indiana, and is a member of the Board of Get-in Chicago, an
organization focused on preventing gang violence in Chicago, since 2013.
His
business interests include sports and entertainment, real estate, waste
management, his cannabis and CBD products company, VESL Oils, and more. Notably,
Mr. Thomas has developed a highly successful champagne business with Cheurlin
Champagnes, where he has cultivated an excellent relationship with both the
grower, employees and the French government. Mr. Thomas now uniquely owns
genetics for the grapes produced for the champagne and has perfected an
international import/export system for international distribution of the
product.
Mr.
Thomas inherits the reins of an ascendant international hemp and cannabis
company which under Mr. Ellins’ leadership has seen significant development and
progress, including the establishment of highly scalable farm and production
facilities in Colombia, a portfolio of fully registered elite and government
approved genetic strains, and a state sanctioned THC quota.
The
Board of Directors is grateful to Mr. Ellins and thanks him for his innovation,
dedication, and determination.
“We
are elated to welcome Isiah Thomas to the One World Pharma leadership team and
to have him continue and expand upon the successes of Craig Ellins,” stated Dr.
Kenneth Perego, Executive Chairman of One World Pharma. “Mr. Thomas is the
ideal person to lead us in this new phase as we commence commercial sales and
revenues, lending to our cause his international business experience, myriad
relationships, and commitment to winning.”
“It
is truly an honor to work with Mr. Thomas on the One World Pharma opportunity
and to leverage his experience in such similar verticals to the benefit of the
Company, its shareholders and our indigenous partners in Colombia,” added Brian
Moore, President, One World Pharma.
“I
am honored to join One World Pharma and its excellent team. It is a company that is leading the way in
innovation in the hemp and cannabis industry,” said Isiah Thomas, CEO and
Vice-Chairman. “The company’s deep commitment to excellence in their products
and for its customers positions us well to continue to grow as an international
leader in the industry. Its recognition for its humanitarian efforts validates
its mission as a socially conscious company in a true partnership with the
indigenous people.”
The Valens Company (TSX:
VLNS) (OTCQX:
VLNCF) announced a
custom manufacturing agreement with TREC
Brands Inc., a cannabis brand house with a mission of doing good.
Under
the agreement between The Valens Company and TREC Brands, The Valens Company
will manufacture vape pens across three existing TREC brands; Thumbs Up Brand,
WINK, and Blissed, with the potential to later produce other innovative
products. TREC has already launched a successful line of tinctures, flower, and
pre-rolls, but through this partnership, vape pens will be introduced as a new
product format across its current brand portfolio. The TREC Agreement follows a
royalty-based payment structure.
TREC's
mission is to build socially conscious, purposeful brands with commitments to
initiatives that positively impact Canadian communities, the planet, and society
as a whole. Each brand in their portfolio has a distinct mission that reflects
the core values of the brand house:
●
WINK curates unique products and partners
with local designers to collaborate on accessories. The brand donates 10% of
profits to advance local communities with a focus on progressing culture in
fashion, art and music.
●
Blissed strives to empower women to shed
stigma and live happier, healthier and more authentic existences through
educational content, community building and purposefully designed products.
●
Thumbs Up Brand aims to deliver high
quality cannabis at a fair price to the grower and the consumer.
The
execution of the TREC Agreement further solidifies the strength in The Valens
Company's customized manufacturing platform that both Licensed Producers and
CPG partners utilize to launch products and further their brands in the
evolving Canadian market. The Company remains focused on its further
development into a leading manufacturer of cannabinoid-based products and
continues to broaden its customer product platform from its existing offering
of capsules, tinctures, sprays, vapes, beverages, concentrates, distillate,
isolate, and SōRSE by Valens emulsion, and expects to also include topicals and
edibles in the near to medium term. With this platform, The Valens Company
leads the industry as a one-stop-shop and manufacturer of high quality
oil-based product formats.
"Through
this partnership, The Valens Company and TREC will thoughtfully bring to market
high-quality, bespoke products while putting the unique needs of Canadian
consumers at the forefront of product development," said Tyler Robson, CEO
of The Valens Company. "As Cannabis 2.0 continues to allow for exciting
new products and brands to hit shelves in Canada, we are excited to develop
products in partnership with authentic, community-centric brands such as those
in the TREC portfolio."
"With
The Valens Company's capabilities and expertise to provide customized products
to suit each of our brands, we are confident that we are delivering the best
possible products to our consumers with a company who values community-level
engagement as much as we do," said Trang Trinh, Founding Director and CEO
of TREC Brands.
Hollister
Biosciences Inc. (CSE:
HOLL) (OTC:
HSTRF) announced that
the Company's 100% owned subsidiary, AlphaMind Brands Inc. plans to launch
medicinal mushroom based capsule and powder product lines.
The
initial product line will consist of a blended and bottled powder and capsule
consisting of powdered cordyceps, lion's mane, oyster, reishi and shiitake
medicinal mushroom varietals. The
formulations for both products are unique and developed through research driven
initiatives. The health benefits that
the capsules and powder intend to provide include but are not limited to
anti-inflammatory, antioxidant, anti-aging, anti-microbial and immune system
support.
Raw
materials for the product line have arrived at Alphamind's manufacturing
partner, Kirkman and have been sent off for third party testing. Once the ingredients are approved, AlphaMind
anticipates production can begin by mid-June with the aim of having the product
line in the market by mid-July 2020.
Dr.
Nikos Apostolopoulos, CSO of AlphaMind shared, "Our AlphaMind five
mushroom blend will be a game changer for both athletes and non-athletes alike.
This ethically sourced and organically grown blend provides potent
antioxidants, and anti-inflammatory responses, helping to improve and maximize
performance as well as daily activities."
Once again, today’s
podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an
ucts
or services or securities. Investors are reminded all investment involves risk
and possible loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: CSUI is a paid news and social media sock on
investor ideas. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
